NBP NovaBridge Biosciences - American Depositary Shares
$1.75
Price · May 20, 2026
52W Range
$1–$7
14% of range
Analyst Rating
BUY
9 analysts
Price Target
$8
+357% upside
P/E (TTM)
—
ROE
—
Net Profit Margin
—
NBP Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$1.75
Market Cap
—
P/E (TTM)
—
EPS (TTM)
—
Revenue (TTM)
—
Div Yield
—
ROE
—
Debt/Equity
—
52W Range
$1 – $7
NBP Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
—
EPS
—
Free Cash Flow
—
Margins
—
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
NBP
Peer Median
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
NBP
Peer Median
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
NBP
Peer Median
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
NBP
Peer Median
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
NBP
Peer Median
NBP Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
BUY
9 analysts
- Strong Buy 3 33.3%
- Buy 5 55.6%
- Hold 1 11.1%
- Sell 0 0.0%
- Strong Sell 0 0.0%
12-Month Price Target
3 analysts · 2026-05-20
Median
$8.00
← Below all targets
$1.75
Low
$7.00
High
$9.00
Median target
$8.00
+357.3%
Mean target
$8.00
+357.3%
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-0.04%
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| Dec. 31, 2025 | $-0.29 | $-0.05 | -0.24% |
| Sept. 30, 2025 | $-0.03 | $-0.05 | 0.02% |
| June 30, 2025 | $-0.07 | $-0.04 | -0.03% |
| March 31, 2025 | $-0.03 | $-0.07 | 0.04% |
| Dec. 31, 2024 | $-0.08 | $-0.06 | -0.02% |
| Sept. 30, 2024 | $-0.25 | $-0.23 | -0.02% |
Peer Comparison Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| NBP | — | — | — | — | — | — |
| ANIK | $133M | -12.6 | -5.9% | -9.6% | -7.5% | 56.6% |
| NKTX | $131M | -1.3 | — | — | -31.1% | — |
| CRBU | $151M | -1.0 | 11.7% | -1327.4% | -102.8% | — |
| TLSI | — | — | — | — | — | — |
| ARCT | $174M | -2.6 | -46.1% | -80.2% | -29.6% | — |
| IMDX | $215M | -4.5 | 115.6% | -1238.5% | 330.8% | 56.7% |
| ELTX | — | -3.1 | — | — | — | — |
| ARTV | — | -1.3 | -99.2% | — | — | — |
| RNAC | $188M | -1.4 | -92.8% | -4658.6% | 202.4% | — |
| DTIL | $100M | -1.2 | -50.1% | -133.4% | -72.4% | — |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.